Market Research Logo

Hong Kong Pharmaceuticals and Healthcare Report Q2 2016

Hong Kong Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The ageing of Hong Kong's demography will necessitate changes to its healthcare system. Top of the agenda will be healthcare financing, as authorities face rising medical costs as chronic diseases rise and tax revenues decline due to the rising dependency ratio. Similarly, healthcare delivery will be a key area of focus as the special administrative region augments the existing medical resources to cope with demand.

Headline Expenditure Projections

Pharmaceuticals: HKD13.0bn (USD1.7bn) in 2015 to HKD13.7bn (USD1.7bn) in 2016; +5.7% in local currency and 5.4% US dollars terms.

Healthcare: HKD140.4bn (USD18.1bn) in 2015 to HKD149.7bn (USD19.3bn) in 2016; +6.7% in local currency and 6.4% in US dollars terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Hong Kong 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020)
OTC Medicine Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2014-2020)
Industry Risk/Reward Index
Asia Pacific Risk/Reward Index
Hong Kong Risk/Reward Index
Rewards
Risks
Regulatory Review
Table: Processed Applications
Intellectual Property Issues
Pricing And Reimbursement Regime
Table: Number Of Drugs In Drug Formulary
Market Overview
Healthcare Sector
Table: Healthcare Resources (Hong Kong 2010-2015)
Table: Healthcare Personnel (Hong Kong 2010-2015)
Table: Healthcare Activity (Hong Kong 2010-2015)
Clinical Trials
Table: Top Causes Of Deaths In Hong Kong
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Wuyi International Pharmaceutical
CK Life Sciences
GlaxoSmithKline
Pfizer
Sanofi
Merck & Co
Novartis
Demographic Forecast
Table: Population Headline Indicators (Hong Kong 1990-2025)
Table: Key Population Ratios (Hong Kong 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Hong Kong 1990-2025)
Table: Population By Age Group (Hong Kong 1990-2025)
Table: Population By Age Group % (Hong Kong 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report